Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Couch

Showing results (281-290 of 697) with videos related to

Pageof 70
Sort By:
Cancer|February 4, 2020
Reply to On the proportion of male breast cancer among all breast cancersSiddhartha Yadav, Dhauna Karam, Irbaz Bin Riaz, et al.
Biomed Research International|June 25, 2015
Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal AdenocarcinomaAlan R Penheiter, Sibel Erdogan, Stephen J Murphy, et al.
Gastroenterology|August 6, 2013
Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumorStephen J Murphy, Steven N Hart, Joema Felipe Lima, et al.
International Journal of Molecular Sciences|March 25, 2017
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE SpecimensOlivier Loudig, Tao Wang, Kenny Ye, et al.
Breast Cancer Research : BCR|November 27, 2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock, Amanda B Spurdle, Myth T S Mok, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
American Journal of Human Genetics|February 20, 2021
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significanceMarcy E Richardson, Chunling Hu, Kun Y Lee, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
JNCI Cancer Spectrum|August 10, 2023
Changes in amount and intensity of physical activity over time in breast cancer survivorsPaulina S Marell, Robert A Vierkant, Janet E Olson, et al.
Cancer Research Communications|November 29, 2023
Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 MutationEmma Guyonnet, Shana J Kim, Yue Yin Xia, et al.
Pageof 70

Showing results (281-290 of 697) with videos related to

Sort By:
Pageof 70
Cancer|February 4, 2020
Reply to On the proportion of male breast cancer among all breast cancersSiddhartha Yadav, Dhauna Karam, Irbaz Bin Riaz, et al.
Biomed Research International|June 25, 2015
Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal AdenocarcinomaAlan R Penheiter, Sibel Erdogan, Stephen J Murphy, et al.
Gastroenterology|August 6, 2013
Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumorStephen J Murphy, Steven N Hart, Joema Felipe Lima, et al.
International Journal of Molecular Sciences|March 25, 2017
Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE SpecimensOlivier Loudig, Tao Wang, Kenny Ye, et al.
Breast Cancer Research : BCR|November 27, 2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?Paul K Lovelock, Amanda B Spurdle, Myth T S Mok, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
American Journal of Human Genetics|February 20, 2021
Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significanceMarcy E Richardson, Chunling Hu, Kun Y Lee, et al.
Science Translational Medicine|January 14, 2026
Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancerJulie R Duffield, Xiaonan Hou, Benjamin W Wilson, et al.
JNCI Cancer Spectrum|August 10, 2023
Changes in amount and intensity of physical activity over time in breast cancer survivorsPaulina S Marell, Robert A Vierkant, Janet E Olson, et al.
Cancer Research Communications|November 29, 2023
Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 MutationEmma Guyonnet, Shana J Kim, Yue Yin Xia, et al.
Pageof 70